Health Trials

CDH17-positive Advanced Malignant Solid Tumors

1

Review clinical trials related to CDH17-positive Advanced Malignant Solid Tumors. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Recruiting

Anti-CDH17 CAR-T Cell Injection in Patients With CDH17-positive Advanced Malignant Solid Tumors

This is a single-arm, open-label, exploratory clinical study to evaluate the safety and preliminary efficacy of Anti-CDH17 CAR-T cell injection in patients with CDH17-positive advanced malignant solid tumors.

Participants needed: 17
Trial details
Phase: Phase 1Age: 18-70Biological sex: AllType: InterventionalSponsor: Shanghai Pudong HospitalUpdated: Jul 15, 2024Locations: 1
Eligibility criteria

18 to 70 years old (including cut-off value), gender is not limited. [+8]

Patients have received systemic therapy with cytotoxic chemicals, monoclonal ant... [+26]

Read more